the Securities Exchange Act of 1934 (Amendment
No. )
On March 19, 2018, Joseph Stilwell and affiliated entities filed
Amendment No. 16 to their Schedule 13D relating to HopFed Bancorp, Inc., a copy of which is filed herewith.
SECURITY HOLDERS ARE ADVISED TO READ THE PROXY STATEMENT AND
OTHER DOCUMENTS RELATING TO THE SOLICITATION OF PROXIES BY THE GROUP AND OTHER PARTICIPANTS FROM THE STOCKHOLDERS OF HOPFED BANCORP,
INC. FOR USE AT ITS 2018 ANNUAL MEETING OF STOCKHOLDERS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION,
INCLUDING INFORMATION RELATING TO THE PARTICIPANTS IN SUCH PROXY SOLICITATION. WHEN COMPLETED, A DEFINITIVE PROXY STATEMENT AND
A FORM OF PROXY WILL BE MAILED TO STOCKHOLDERS OF HOPFED BANCORP, INC. AND WILL ALSO BE AVAILABLE AT NO CHARGE AT THE SECURITIES
AND EXCHANGE COMMISSION'S WEBSITE AT HTTP://WWW.SEC.GOV.
Mr. Joseph Stilwell
If the filing person has previously filed
a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because
of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
¨
The information required on the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act
of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
Item 3. Source and Amount of Funds or Other Consideration
All purchases of shares
of Common Stock made by the Group using funds borrowed from Fidelity Brokerage Services LLC or Morgan Stanley, if any, were made
in margin transactions on their usual terms and conditions. All or part of the shares of Common Stock owned by members of the
Group may from time to time be pledged with one or more banking institutions or brokerage firms as collateral for loans made by
such entities to members of the Group. Such loans generally bear interest at a rate based on the broker’s call rate from
time to time in effect. Such indebtedness, if any, may be refinanced with other banks or broker-dealers.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
8 of 38
|
Item 4. Purpose of Transaction
We are filing this Sixteenth Amendment
to announce our nominee and alternate nominees for the Issuer’s upcoming election of directors. We believe CEO and Director,
John E. Peck, should be removed from the Issuer and/or the Issuer should be sold.
Copies of the agreements with our nominees
are attached as Exhibits 16, 17 and 18 to this Sixteenth Amendment.
Our purpose in acquiring shares of Common
Stock of the Issuer is to profit from the appreciation in the market price of the shares of Common Stock through asserting shareholder
rights. We do not believe the value of the Issuer’s assets is adequately reflected in the current market price of the Issuer’s
Common Stock.
At HFBC’s May 2013 annual meeting,
we nominated a director for the Board of Directors and strongly opposed HFBC’s agreement to purchase Sumner Bank & Trust.
Our nominee won by a two to one margin, and the proposed Sumner deal was subsequently terminated in August 2013.
On May 1, 2017, we sent a letter to stockholders
(filed as Exhibit 13 to the Twelfth Amendment) detailing the personal property holdings of HFBC’s CEO, John Peck, as well
as numerous other conflicts of interest uncovered in our review of publicly available documents. In response to our letter, HFBC
announced the formation of a “Special Litigation Committee.”
On May 4, 2017, we filed a complaint in
the Delaware Court of Chancery against HFBC, the current members of the Board of Directors and one former board member, asking
the Court to declare that HFBC’s prejudicial bylaw was invalid and that the directors breached their fiduciary duties. On
October 4, 2017, HFBC announced it had amended the bylaw thus mooting that case. Subsequently, we filed a motion to recover our
attorneys’ fees and expenses, which Vice Chancellor J. Travis Laster granted in its entirety on February 7, 2018, awarding
us $610,312. In his ruling on the motion, the Judge excoriated the conduct of HFBC’s board; the full court transcript is
filed as Exhibit 14 to the Fourteenth Amendment.
On February 23, 2018, we demanded that
the Issuer’s Board of Directors take action against the Issuer’s attorneys, Edward B. Crosland, Jr. of Jones Walker
LLP and George M. “Greg” Carter of Carter & Carter Law Firm, for legal malpractice and seek damages in excess
of $1 million to the Issuer. Our demand letter is attached as Exhibit 15 to the Fifteenth Amendment.
THIS SIXTEENTH AMENDMENT MAY BE DEEMED
TO BE SOLICITATION MATERIAL IN RESPECT OF THE SOLICITATION OF PROXIES BY THE GROUP FROM THE ISSUER'S STOCKHOLDERS IN CONNECTION
WITH THE ISSUER'S 2018 ANNUAL MEETING. SECURITY HOLDERS ARE ADVISED TO READ THE PROXY STATEMENT AND OTHER DOCUMENTS RELATING TO
THE SOLICITATION BY THE GROUP AND OTHER PARTICIPANTS OF PROXIES FROM THE ISSUER’S STOCKHOLDERS FOR USE AT THE ISSUER’S
2018 ANNUAL MEETING OF STOCKHOLDERS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION, INCLUDING INFORMATION
RELATING TO THE PARTICIPANTS IN OUR PROXY SOLICITATION. WHEN COMPLETED, A DEFINITIVE PROXY STATEMENT AND A FORM OF PROXY WILL
BE MAILED TO STOCKHOLDERS OF THE ISSUER AND WILL ALSO BE AVAILABLE AT NO CHARGE AT THE SECURITIES AND EXCHANGE COMMISSION’S
WEBSITE AT HTTP://WWW.SEC.GOV. INFORMATION RELATING TO THE PARTICIPANTS IN OUR PROXY SOLICITATION IS INCLUDED IN APPENDIX A HERETO
AND INCORPORATED BY REFERENCE HEREIN.
Since 2000, members or affiliates
of the Group have taken an ‘activist position’ in 64 other publicly-traded companies. Currently, members or affiliates
of the Group file Schedule 13Ds to disclose greater than 5% positions only in SEC-reporting companies. For simplicity, these affiliates
are referred to below as the “Group”, “we”, “us”, or “our.” In each instance,
our purpose has been to profit from the appreciation in the market price of the shares we held by asserting shareholder rights.
In addition, we believed that the values of the companies’ assets were not adequately reflected in the market prices of
their shares. Our actions are described below. We have categorized the descriptions of our actions with regard to the issuers
based upon certain outcomes (whether or not, directly or indirectly, such outcomes resulted from the actions of the Group). Within
each category the descriptions are listed in chronological order based upon the respective filing dates of the originally-filed
Schedule 13Ds, or, in limited instances, the acquisition date of our 5% position of a non-reporting company.
I.
Security of Pennsylvania
Financial Corp. (“SPN”)
- We filed our original Schedule 13D to report our position on May 1, 2000. We scheduled
a meeting with senior management to discuss ways to maximize the value of SPN’s assets. On June 2, 2000, prior to the scheduled
meeting, SPN and Northeast Pennsylvania Financial Corp. announced SPN’s acquisition.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
9 of 38
|
Cameron Financial
Corporation (“Cameron”)
- We filed our original Schedule 13D to report our position on July 7, 2000. We exercised
our shareholder rights by, among other things, requesting that Cameron management hire an investment banker, demanding Cameron’s
list of shareholders, meeting with Cameron’s management, demanding that Cameron invite our representatives to join the board,
writing to other shareholders to express our dismay with management’s inability to maximize shareholder value and publishing
that letter in the local press. On October 6, 2000, Cameron announced its sale to Dickinson Financial Corp.
Community Financial
Corp. (“CFIC”)
- We filed our original Schedule 13D to report our position on January 4, 2001, following CFIC’s
announcement of the sale of two of its four subsidiary banks and its intention to sell one or more of its remaining subsidiaries.
We reported that we acquired CFIC stock for investment purposes. On January 25, 2001, CFIC announced the sale of one of its remaining
subsidiaries. We then announced our intention to run an alternate slate of directors at the 2001 annual meeting if CFIC did not
sell the remaining subsidiary by then. On March 27, 2001, we wrote to CFIC confirming that CFIC’s management had agreed
to meet with one of our proposed nominees to the board. On March 30, 2001, before our meeting took place, CFIC announced its merger
with First Financial Corporation.
Montgomery Financial
Corporation (“Montgomery”)
- We filed our original Schedule 13D to report our position on February 23, 2001. On
April 20, 2001, we met with Montgomery’s management and suggested that they maximize shareholder value by selling the institution.
We also informed management that we would run an alternate slate of directors at the 2001 annual meeting unless Montgomery was
sold. Eleven days after we filed our Schedule 13D, however, Montgomery’s board amended its bylaws to limit the pool of potential
nominees to local persons with a banking relation and to shorten the deadline to nominate an alternate slate. We located qualified
nominees under the restrictive bylaw provisions and noticed our slate within the deadline. On June 5, 2001, Montgomery announced
that it had hired an investment banker to explore a sale. On July 24, 2001, Montgomery announced its merger with Union Community
Bancorp.
Community Bancshares,
Inc. (“COMB”)
- We filed our original Schedule 13D reporting our position on March 29, 2004. We disclosed that
we intended to meet with COMB’s management and evaluate management’s progress in resolving its regulatory issues,
lawsuits, problem loans, and non-performing assets, and that we would likely support management if it effectively addressed COMB’s
challenges. On November 21, 2005, we amended our Schedule 13D and stated that although we believed that COMB’s management
had made progress, COMB’s return on equity would likely remain below average for the foreseeable future, and it should therefore
be sold. We also stated that if COMB did not announce a sale before our deadline to solicit proxies for the next annual meeting,
we would solicit proxies to elect our own slate. On January 6, 2006, we disclosed the names of our three board nominees. On May
1, 2006, COMB announced its sale to The Banc Corporation.
FedFirst Financial
Corporation (“FFCO”)
- We filed our original Schedule 13D reporting our position on September 24, 2010. After
several meetings with management, FFCO completed a meaningful number of share repurchases, and on April 14, 2014, FFCO announced
its sale to CB Financial Services, Inc.
SP Bancorp, Inc.
(“SPBC”)
- We filed our original Schedule 13D reporting our position on February 28, 2011. On August 9, 2013,
we met with management and the chairman to assess the best way to maximize shareholder value. SPBC completed a meaningful number
of share repurchases, and on May 5, 2014, SPBC announced its sale to Green Bancorp Inc.
TF Financial Corporation
(“THRD”)
- We filed our original Schedule 13D reporting our position on November 29, 2012. We met with the CEO
and the chairman, encouraging them to focus only on accretive acquisitions and to repurchase shares up to book value. They subsequently
did both. On June 4, 2014, THRD announced its sale to National Penn Bancshares, Inc.
Jefferson Bancshares,
Inc. (“JFBI”)
- We filed our original Schedule 13D reporting our position on April 8, 2013. Our shareholder proposal
requesting the board seek outside assistance to maximize shareholder value through actions such as a sale or merger was defeated
at JFBI’s 2013 annual meeting. We met with management and the board of directors and told them that we would seek board
representation at JFBI’s 2014 annual meeting if JFBI did not announce its sale. JFBI announced its sale on January 23, 2014.
Fairmount Bancorp,
Inc. (“FMTB”)
- We filed our original Schedule 13D reporting our position on September 21, 2012. On February 25,
2014, we reported our intention to seek board representation at FMTB’s 2015 annual meeting if FMTB did not announce its
sale. However, due to the appointment of our representative to another board in the local area, we were unable to nominate our
representative at the 2015 election of FMTB directors. We reiterated our intent to seek board representation at the earliest possible
time if FMTB was not sold. FMTB’s sale was announced on April 16, 2015.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
10 of 38
|
Harvard Illinois
Bancorp, Inc. (“HARI”)
- We filed our original Schedule 13D reporting our position on April 1, 2011. In 2012,
we nominated a director for election at HARI’s 2012 annual meeting and communicated our belief that HARI should merge with
a stronger community bank. Our nominee was not elected, so we nominated a director at HARI’s 2013 annual meeting and stated
our position that HARI should be sold. We communicated to stockholders our intent to run a nominee every year until elected, and
we nominated a director at HARI’s 2014 annual meeting. Our nominee was not elected, so in April 2015, we began soliciting
stockholder votes for our nominee for HARI’s 2015 annual meeting. On May 21, 2015, HARI announced the sale of its subsidiary
bank to State Bank in Wonder Lake, IL. We subsequently withdrew our solicitation of proxies for the election of our nominee
at HARI’s 2015 annual meeting. The sale of HARI’s subsidiary bank was completed on August 1, 2016. On August 10, 2016,
we entered into a settlement agreement with HARI whereby two legacy board members stepped down, and we agreed not to seek board
representation through 2017. HARI is implementing a plan of voluntary dissolution.
Eureka Financial
Corp. (“EKFC”)
- We filed our original Schedule 13D reporting our position on March 28, 2011. We encouraged
EKFC to pay special dividends to shareholders and repurchase shares. Management and the board did both, and on September
3, 2015, EKFC announced its sale to NexTier, Inc.
United-American
Savings Bank (“UASB”)
- We filed our original Schedule 13D with the Federal Deposit Insurance Corporation reporting
our position on May 20, 2013. We believe management and the board acted in good faith to position UASB to maximize shareholder
value. After we encouraged them to sell, UASB announced its sale to Emclaire Financial Corp on December 30, 2015.
Polonia Bancorp,
Inc. (“PBCP”)
- We filed our original Schedule 13D reporting our position on November 23, 2012. After several
conversations with the Chairman and CEO, we publicly called for PBCP's sale. On June 2, 2016, PBCP's sale to Prudential Bancorp,
Inc. was announced.
Georgetown Bancorp,
Inc. (“GTWN”)
- We filed our original Schedule 13D reporting our position on July 23, 2012. We encouraged GTWN
to maximize shareholder value through share repurchases, and we supported management and the board’s consistent efforts
to do so. On October 6, 2016, GTWN announced its sale to Salem Five Bancorp.
Anchor Bancorp
(“ANCB”)
- We filed our original Schedule 13D reporting our position on May 7, 2012. We previously urged ANCB
to maximize shareholder value by increasing share repurchases or selling the bank. We called for ANCB’s sale to the highest
bidder on July 7, 2016. On August 29, 2016, we agreed not to seek board representation at the 2016 annual meeting in consideration
of ANCB appointing Gordon Stephenson as a director. We believe the board has acted in good faith to maximize shareholder value
through ANCB’s announced sale to Washington Federal, Inc. on April 11, 2017.
Wolverine Bancorp,
Inc. (“WBKC”)
- We filed our original Schedule 13D reporting our position on February 7, 2011. We encouraged
WBKC to maximize shareholder value through share repurchases and payments of special dividends, and we supported management and
the board’s consistent efforts to do so. On June 14, 2017, WBKC’s sale to Horizon Bancorp was announced.
First Federal of
Northern Michigan Bancorp, Inc. (“FFNM”)
- We filed our original Schedule 13D reporting our position on March
10, 2016. We believed FFNM was positioned to repurchase shares, and we urged management and the board to do so. FFNM deregistered
its shares of common stock effective in 2016. On January 16, 2018, FFNM’s sale to Mackinac Financial Corporation was announced.
Jacksonville Bancorp, Inc. (“JXSB”)
-
We filed our original Schedule 13D reporting our position on July 5, 2011. We supported JXSB’s consistent efforts to maximize
shareholder value through share repurchases and payments of special dividends. On January 18, 2018, JXSB’s sale to CNB Bank
Shares, Inc. was announced.
II.
HCB Bancshares,
Inc. (“HCBB”)
- We filed our original Schedule 13D reporting our position on June 14, 2001. On September 4, 2001,
we reported that we had entered into a standstill agreement with HCBB, under which HCBB agreed to: (a) add a director selected
by us, (b) consider conducting a Dutch tender auction, (c) institute annual financial targets, and (d) retain an investment banker
to explore alternatives if it did not achieve its financial targets. On October 22, 2001, our nominee, John G. Rich, Esq., was
named to the board. On January 31, 2002, HCBB announced a modified Dutch tender auction to repurchase 20% of its shares. Although
HCBB’s outstanding share count decreased by 33% between the filing of our original Schedule 13D and August 2003, HCBB did
not achieve the financial target. On August 12, 2003, HCBB announced it had hired an investment banker to assist in exploring
alternatives for maximizing shareholder value, including a sale. On January 14, 2004, HCBB announced its sale to Rock Bancshares
Inc.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
11 of 38
|
Oregon Trail Financial
Corp. (“OTFC”)
- We filed our original Schedule 13D reporting our position on December 15, 2000. In January 2001,
we met with the management of OTFC to discuss our concerns that management was not maximizing shareholder value, and we proposed
that OTFC voluntarily place our representative on the board. OTFC rejected our proposal, and we announced our intention to solicit
proxies to elect a board nominee. We demanded OTFC’s shareholder list, but OTFC refused to give it to us. We sued OTFC in
Baker County, Oregon, and the court ruled in our favor and sanctioned OTFC. We also sued two OTFC directors alleging that one
had violated OTFC’s residency requirement and that the other had committed perjury. Both suits were dismissed pre-trial
but we filed an appeal in one suit and were permitted to re-file the other suit in state court. On August 16, 2001, we started
soliciting proxies to elect Kevin D. Padrick, Esq. to the board. We argued in our proxy materials that OTFC should have repurchased
its shares at prices below book value. OTFC announced the hiring of an investment banker. Then, the day after the 9/11 attacks,
OTFC sued us in Portland, Oregon and moved to invalidate our proxies; the court denied the motion and the election proceeded.
On October 12, 2001,
OTFC’s shareholders elected our candidate by a two-to-one margin. In the five months after the filing of our first proxy
statement (i.e., from August 1 through December 31, 2001), OTFC repurchased approximately 15% of its shares. On March 12, 2002,
we entered into a standstill agreement with OTFC. OTFC agreed to: (a) achieve annual targets for return on equity, (b) reduce
its current capital ratio, (c) obtain advice from an investment banker regarding annual 10% stock repurchases, (d) re-elect our
director to the board, (e) reimburse a portion of our expenses, and (f) withdraw its lawsuit. On February 24, 2003, OTFC and FirstBank
NW Corp. announced their merger.
American Physicians
Capital, Inc. (“ACAP”)
- We filed our original Schedule 13D reporting our position on November 25, 2002. The Schedule
13D disclosed that on January 18, 2002, Michigan’s Insurance Department had approved our request to solicit proxies to elect
two directors to ACAP’s board. On January 29, 2002, we noticed our intention to nominate two directors at the 2002 annual
meeting. On February 20, 2002, we entered into a three-year standstill agreement with ACAP, providing for ACAP to add our nominee
to its board. ACAP also agreed to consider using a portion of its excess capital to repurchase ACAP’s shares in each of
the fiscal years 2002 and 2003 so that its outstanding share count would decrease by 15% for each of those years. In its 2002
fiscal year, ACAP repurchased 15% of its outstanding shares; these repurchases were highly accretive to per share book value.
On November 6, 2003, ACAP announced a reserve charge and that it would explore options to maximize shareholder value. It also
announced that it would exit the healthcare and workers’ compensation insurance businesses. ACAP then announced that it
had retained Sandler O’Neill & Partners, L.P., to assist the board. On December 2, 2003, ACAP announced the early retirement
of its president and CEO. On December 23, 2003, ACAP named R. Kevin Clinton its new president and CEO.
On June 24, 2004,
ACAP announced that it had decided that the best means to maximize shareholder value would be to shed non-core businesses and
focus on its core business line in its core markets. We increased our holdings in ACAP, and we announced that we intended to seek
additional board representation. On November 10, 2004, ACAP invited Joseph Stilwell to sit on the board, and we entered into a
new standstill agreement. This agreement was terminated in November 2007, with our representatives remaining on ACAP’s board.
On May 8, 2008, our representatives were re-elected to three-year terms expiring in 2011. Upon the passage of federal healthcare
legislation in 2010, ACAP became concerned about the fundamentals of its business and promptly acted to assess its strategic alternatives.
On October 22, 2010, ACAP was acquired by The Doctors Company, and our shares were converted in a cash deal.
SCPIE Holdings
Inc. (“SKP”)
- We filed our original Schedule 13D reporting our position on January 19, 2006. We announced we
would run our slate of directors at the 2006 annual meeting and demanded SKP’s shareholder list. SKP initially refused to
timely produce the list, but did so after we sued it in Delaware Chancery Court. We engaged in a proxy contest at the 2006 annual
meeting, but SKP’s directors were elected. Subsequently on December 14, 2006, SKP agreed to place Joseph Stilwell on its
board. On October 16, 2007, Mr. Stilwell resigned from SKP’s board after it approved a sale of SKP that Mr. Stilwell believed
was an inferior offer. We solicited shareholder proxies in opposition to the proposed sale; however, the sale was approved, and
our shares were converted in a cash deal.
Colonial Financial
Services, Inc. (“COBK”)
- We filed our original Schedule 13D reporting our position on August 24, 2011. On December
18, 2013, we reached an agreement with COBK to have a director of our choice appointed to its board of directors. Our nominee,
Corissa J. Briglia, joined COBK’s board of directors on March 25, 2014. On September 10, 2014, COBK announced its sale to
Cape Bancorp, Inc., and the cash/stock deal was completed on April 1, 2015.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
12 of 38
|
Naugatuck Valley
Financial Corporation (“NVSL”)
- We filed our original Schedule 13D reporting our position on July 11, 2011. On
February 13, 2014, we reported our intention to seek board representation. On March 12, 2014, we reached an agreement with NVSL
for our representative to join NVSL's board of directors and for NVSL not to seek approval for stock benefit plans. On June 4,
2015, NVSL announced its sale to Liberty Bank in Middletown, CT, and the cash deal was completed on January 15, 2016.
Fraternity Community
Bancorp, Inc. (“FRTR”)
- We filed our original Schedule 13D reporting our position on April 11, 2011. We reached
an agreement with FRTR, and on November 18, 2014, our representative, Corissa J. Briglia, was appointed to the board of directors. On
October 13, 2015, FRTR's sale was announced, and the cash deal was completed on May 13, 2016.
Delanco Bancorp,
Inc. (“DLNO”)
- We filed our original Schedule 13D reporting our position on October 28, 2013. We reached
an agreement with DLNO, and in May 2017, our representative, Corissa J. Briglia, was appointed to the board of directors. On October
18, 2017, DLNO’s sale to First Bank was announced.
Sunshine Financial,
Inc. (“SSNF”)
- We filed our original Schedule 13D reporting our position on April 18, 2011. We reached an agreement
with SSNF, and on February 5, 2016, our representative, Corissa J. Briglia, was appointed to the board of directors. On December
6, 2017, SSNF’s sale to The First Bancshares, Inc. was announced.
III.
FPIC Insurance
Group, Inc. (“FPIC”)
- We filed our original Schedule 13D reporting our position on June 30, 2003. On August 12,
2003, Florida’s Insurance Department approved our request to hold more than 5% of FPIC’s shares, to solicit proxies
to hold board seats, and to exercise shareholder rights. On November 10, 2003, FPIC invited our nominee, John G. Rich, Esq., to
join the board, and we signed a confidentiality agreement. On June 7, 2004, we disclosed that because FPIC had taken steps to
increase shareholder value, such as multiple share repurchases, and because its market price increased and reflected fair value
in our estimation, we sold our shares in the open market, decreasing our holdings below 5%. Our nominee was invited to remain
on the board.
Prudential Bancorp,
Inc. of Pennsylvania (“PBIP”)
- We filed our original Schedule 13D reporting our position on June 20, 2005. Most
of PBIP’s shares were held by the Prudential Mutual Holding Company (the “MHC”), which was controlled by PBIP’s
board. The MHC controlled most corporate decisions requiring a shareholder vote, such as the election of directors. However, regulations
promulgated by the FDIC previously barred the MHC from voting on PBIP’s management stock benefit plans, and PBIP’s
IPO prospectus indicated that the MHC would not vote on the plans. We announced in August 2005 that we would solicit proxies to
oppose adoption of the plans as a referendum to place Joseph Stilwell on PBIP’s board. PBIP decided not to put the plans
up for a vote at the 2006 annual meeting.
In December 2005,
we solicited proxies to withhold votes on the election of directors as a referendum to place Mr. Stilwell on the board. At the
2006 annual meeting, 71% of PBIP’s voting public shares were withheld from voting on management’s nominees.
On April 6, 2006,
PBIP announced that just after we had filed our Schedule 13D, it had secretly solicited a letter from an FDIC staffer (which it
concealed from the public) that the MHC would be allowed to vote in favor of the management stock benefit plans. PBIP also announced
a special meeting to vote on the plans. We alerted the Board of Governors of the Federal Reserve System (the “Fed”)
about this announcement, and PBIP was directed to seek Fed approval before adopting the plans. On April 19, 2006, PBIP postponed
the special meeting. The Fed subsequently followed the FDIC’s position in September 2006. In December 2006, we solicited
proxies to withhold votes on the election of PBIP’s directors at the 2007 annual meeting. At the meeting, 75% of PBIP’s
voting public shares were withheld. Also during the annual meeting, PBIP’s President and Chief Executive Officer was unable
to state the meaning of per share return on equity despite Mr. Stilwell’s holding up a $10,000 check for the charity of
the CEO’s choice if he could promptly answer the question. On March 7, 2007, we disclosed that we were publicizing the results
of PBIP’s elections and its directors’ unwillingness to hold a democratic vote on the stock plans by placing billboard
advertisements throughout Philadelphia.
In December 2007,
we filed proxy materials for the solicitation of proxies to withhold votes on the election of PBIP’s directors at the 2008
annual meeting. At the 2008 annual meeting, an average of 77% of PBIP’s voting public shares withheld their votes. Excluding
shares held in PBIP’s ESOP, an average of 88% of the voting public shares withheld their votes in this election.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
13 of 38
|
On October 4, 2006,
we sued PBIP, the MHC, and the directors of PBIP and the MHC in federal court in Philadelphia seeking an order to prevent the
MHC from voting in favor of the management stock benefit plans. On August 15, 2007, the court dismissed some claims, but sustained
our cause of action against the MHC as majority shareholder of PBIP for breach of fiduciary duties. Discovery proceeded and all
the directors were deposed. Both sides moved for summary judgment, but the court ordered the case to trial, which was scheduled
for June 2008. On May 22, 2008, we voluntarily discontinued the lawsuit after determining that it would be more effective and
appropriate to pursue the directors on a personal basis in a derivative action. On June 11, 2008, we filed a notice to appeal
certain portions of the lower court’s August 15, 2007, order dismissing portions of the lawsuit.
We entered into a
settlement agreement and an expense agreement with PBIP in November 2008 under which we agreed to support PBIP’s management
stock benefit plans, drop our litigation and withdraw our shareholder demand, and generally support management; and in exchange,
PBIP agreed, subject to certain conditions, to repurchase up to three million of its shares (including shares previously purchased),
reimburse a portion of our expenses, and either adopt a second step conversion or add our nominee who meets certain qualification
requirements to its board if the repurchases were not completed by a specified time.
On March 5, 2010,
we reported that our ownership in PBIP had dropped below 5% as a result of open market sales and sales of common stock to PBIP.
Roma Financial
Corp. (“ROMA”)
- We filed our original Schedule 13D reporting our position on July 27, 2006. Prior to its acquisition
by Investors Bancorp, Inc., in December 2013, nearly 70% of ROMA’s shares were held by a mutual holding company controlled
by ROMA’s board. In April 2007, we engaged in a proxy solicitation at ROMA’s first annual meeting, urging shareholders
to withhold their vote from management’s slate. ROMA did not put their stock benefit plans up for a vote at that meeting.
We then met with ROMA management. In the four months after ROMA became eligible to repurchase its shares, it announced and substantially
completed repurchases of 15% of its publicly held shares, which were accretive to shareholder value. In our judgment, management
came to understand the importance of proper capital allocation. Based on ROMA management’s prompt implementation of shareholder-friendly
capital allocation plans, we supported management’s adoption of stock benefit plans at the 2008 shareholder meeting. In
our estimation, ROMA’s market price increased and reflected fair value, and we sold our shares in the open market.
First Savings Financial
Group, Inc. (“FSFG”)
- We filed our original Schedule 13D reporting our position on December 29, 2008. We met
with management, after which FSFG announced a stock repurchase plan and began repurchasing its shares. In December 2009, we reported
that our beneficial ownership in the outstanding FSFG common stock had fallen below 5%.
Alliance Bancorp,
Inc. of Pennsylvania (“ALLB”)
- We filed our original Schedule 13D reporting our position on March 12, 2009. When
we announced our reporting position, a majority of ALLB’s shares were held by a mutual holding company controlled by ALLB’s
board. However, on August 11, 2010, ALLB announced its intention to undertake a second step offering, selling all shares to the
public. The plan of conversion and reorganization was approved by depositors at a special meeting held December 29, 2010. We strongly
supported ALLB’s action. Following completion of the conversion of Alliance Bank from the mutual holding company structure
to the stock holding company structure, we increased our stake with the belief that shareholders and ALLB would do well if management
focused on profitability. We believe management and the board acted in good faith and took steps to increase shareholder value,
such as multiple share repurchases. In our estimation, ALLB’s market price increased and reflected fair value; on November
21, 2013, we disclosed that we sold shares in the open market, decreasing our holdings below 5%.
Standard Financial
Corp. (“STND”)
- We filed our original Schedule 13D reporting our position on October 18, 2010. We believe management
and the board acted in good faith and took steps to increase shareholder value, such as multiple share repurchases. In our estimation,
STND’s market price increased and reflected fair value; on March 19, 2013, we disclosed that we sold our shares in the open
market, decreasing our holdings below 5%.
Home Federal Bancorp,
Inc. of Louisiana (“HFBL”)
- We filed our original Schedule 13D reporting our position on January 3, 2011. We
believe management and the board acted in good faith and took steps to increase shareholder value, such as multiple share repurchases.
In our estimation, HFBL’s market price increased and reflected fair value; on February 7, 2013, we disclosed that we sold
shares in the open market, decreasing our holdings below 5%.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
14 of 38
|
ASB Bancorp, Inc.
(“ASBB”)
- We filed our original Schedule 13D reporting our position on October 24, 2011. On August 23, 2013,
we met with management to assess the best way to maximize shareholder value. We believe management and the board acted in good
faith by cleaning up non-performing assets and repurchasing shares, and ASBB’s market price increased to reflect fair value.
On July 18, 2014, we disclosed that we sold our shares to ASBB.
United Insurance
Holdings Corp. (“UIHC”)
- We filed our original Schedule 13D reporting our position on September 29, 2011. On
December 17, 2012, we disclosed that we sold shares in the open market, decreasing our holdings below 5%.
United Community
Bancorp (“UCBA”)
- We filed our original Schedule 13D reporting our position on January 22, 2013. We believe management
and the board acted in good faith and took steps to increase shareholder value, such as multiple share repurchases. In our estimation,
UCBA’s market price increased to reflect fair value; on November 9, 2015, we disclosed that we sold shares to UCBA, decreasing
our holdings below 5%.
West End Indiana
Bancshares, Inc. (“WEIN”)
- We filed our original Schedule 13D reporting our position on January 19, 2012. We
believe management and the board acted in good faith and took steps to increase shareholder value, such as multiple share repurchases.
In our estimation, WEIN’s market price increased to reflect fair value; on November 12, 2015, we disclosed that we sold
our shares in the open market.
First Financial
Northwest, Inc. (“FFNW”)
– We filed our original Schedule 13D reporting our position on September 12, 2011.
At the Company’s 2012 annual meeting, we solicited an overwhelming majority of shareholder votes for our nominee based on
our position that Victor Karpiak (then Chairman and CEO) should be removed from the Company and board. After the Company pushed
to have our votes invalidated, we sued to enforce our rights. In 2013, we settled with the Company. Our nominee, Kevin Padrick,
was seated on the board, and Mr. Karpiak resigned as Chairman. The board later replaced Mr. Karpiak as CEO. We filed two additional
lawsuits arising from the invalidation of our votes at the 2012 election, both of which we settled.
Since 2013, we believed
management and the board acted in good faith by cleaning up non-performing assets and reaching a moderate level of profitability,
and they maximized shareholder value by repurchasing in excess of 40% of FFNW’s shares. In our estimation, FFNW’s
market price increased to reflect fair value; on October 11, 2016, we disclosed that we sold our shares in the open market. Kevin
Padrick continued to serve on the board.
Alamogordo Financial
Corp. (“ALMG”)
- We filed our original Schedule 13D reporting our position on May 11, 2015. We urged management
and the board to provide meaningful returns to shareholders either through a second-step conversion or by effectuating a shareholder-friendly
capital allocation program. On March 7, 2016, ALMG announced and later completed a second-step conversion which we believe maximized
shareholder value. On October 14, 2016, we disclosed that we sold shares of the converted Company, Bancorp 34, Inc., in the open
market, decreasing our holdings below 5%.
William Penn Bancorp,
Inc. (“WMPN”)
- We filed our original Schedule 13D reporting our position on May 23, 2008. A majority of WMPN’s
shares are held by a mutual holding company controlled by WMPN’s board. We met with management and the board to explain
our views on proper capital allocation and following the financial crisis, we continued to urge WMPN to take the steps necessary
to maximize shareholder value. On December 3, 2014, WMPN announced and subsequently completed its plan to repurchase 10% of its
shares outstanding and further completed several additional share repurchases. We believe management and the board acted in good
faith to maximize shareholder value through shareholder-friendly capital allocation; on April 11, 2016, we disclosed that we sold
shares in the open market, decreasing our holdings below 5%.
Malvern Bancorp,
Inc. (“MLVF”)
- We filed our original Schedule 13D reporting our position on May 30, 2008. When we announced our
reporting position, a majority of MLVF’s shares were held by a mutual holding company controlled by MLVF’s board.
On October 26, 2010, we demanded that MLVF pursue a derivative action against its directors for breach of their fiduciary duties.
MLVF failed to pursue the action and, on June 3, 2011, we sued MLVF’s directors in Chester County, Pennsylvania, demanding
that the court, among other things, order the directors to properly consider pursuing a second step conversion. On November 9,
2011, Judge Howard F. Riley Jr. overruled the director defendants’ preliminary objections to the derivative lawsuit.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
15 of 38
|
On January 17, 2012,
MLVF announced its intention to undertake a second step conversion and we withdrew the lawsuit. The conversion and stock offering
were completed on October 11, 2012, and our shares were converted into shares of Malvern Bancorp, Inc. On September 5, 2013, we
notified MLVF of our intention to nominate John P. O’Grady for election as a director at its 2014 annual meeting, but we
later reached an agreement with MLVF for Mr. O’Grady to join its board of directors and executed a standstill agreement.
Subsequently, MLVF’s long-standing CEO resigned, its chairman of the board stepped down and several directors resigned from
the board of directors. On November 25, 2014, we terminated our standstill agreement with MLVF, including the agreement’s
performance targets. John P. O’Grady continued to serve as an independent director on the board but no longer as our nominee.
After meeting with
the new CEO and the new chairman of the board, we believed that management and the board of directors were focused on maximizing
shareholder value and were successful in doing so. On December 7, 2016, we disclosed that we sold shares in the open market, decreasing
our holdings below 5%.
FSB Community Bankshares,
Inc. (“FSBC”)
- We filed our original Schedule 13D reporting our position on October 26, 2015. We urged management
and the board to provide meaningful returns to shareholders either through a second-step conversion or by effectuating a shareholder-friendly
capital allocation program. On March 3, 2016, FSBC announced and later completed a second-step conversion which we believe maximized
shareholder value. On December 9, 2016, we disclosed that we sold shares of the converted Company, FSB Bancorp, Inc., in the open
market, decreasing our holdings below 5%.
Pinnacle Bancshares,
Inc. (“PCLB”)
- We filed our original Schedule 13D reporting our position on September 23, 2014. On November 14,
2014, PCLB announced the continuation of its share repurchase plan and announced a new repurchase plan on May 25, 2016. We believe
management and the board acted in good faith to maximize shareholder value through multiple share repurchases. On December 13,
2016, we disclosed that we sold our shares in the open market.
Sugar Creek Financial
Corp. (“SUGR”)
- We filed our original Schedule 13D reporting our position on April 21, 2014. We believe
management and the board acted in good faith to maximize shareholder value through share repurchases. In our estimation, SUGR’s
market price increased to reflect fair value; on July 28, 2017, we disclosed that we sold our shares in the open market.
Provident Financial
Holdings, Inc. (“PROV”)
- We filed our original Schedule 13D reporting our position on October 7, 2011. We supported
PROV’s consistent efforts to maximize shareholder value through a meaningful number of share repurchases. In our estimation,
PROV’s market price increased and reflected fair value; on September 25, 2017, we disclosed that we sold shares in the open
market, decreasing our holdings below 5%.
IV.
Kingsway Financial
Services Inc. (“KFS”)
- We filed our original Schedule 13D reporting our position on November 7, 2008. We requested
a meeting with its CEO and chairman to discuss ways to maximize shareholder value and minimize both operational and balance sheet
risks, but the CEO was unresponsive. We then requisitioned a special shareholder meeting to remove the CEO and chairman from the
KFS board and replace them with our two nominees. On January 7, 2009, we entered into a settlement agreement with KFS whereby,
among other things, the CEO resigned from the KFS board and KFS expanded its board from nine to ten seats and appointed our nominees
to fill the two vacant seats. By April 23, 2009, the board was reconstituted with just three of the original ten legacy directors
remaining. Also, Joseph Stilwell was appointed to fill the vacancy created by the resignation of one of our nominees, Larry G.
Swets, Jr., and our other nominee was elected chairman of the board. In addition, the CEO and CFO were fired for incompetence
and insubordination.
By November 3, 2009,
all of the legacy directors had resigned from the board. On May 27, 2010, Mr. Stilwell and the Group’s other representative
were re-elected to the board. On June 1, 2010, Mr. Swets was appointed CEO. During the time the Group has had board representation,
KFS has sold non-core assets, repurchased public debt at a discount to face value, sold a credit-sensitive asset, disposed of
its subsidiary Lincoln General, substantially reduced its expenses, and reduced other balance sheet and operations risks.
Poage Bankshares,
Inc. (“PBSK”)
- We filed our original Schedule 13D reporting our position on September 23, 2011. We believed PBSK’s
board was not focused on maximizing shareholder value and nominated a director for election at PBSK's 2014 annual meeting. Our
nominee was not elected, so we nominated a director at PBSK’s 2015 annual meeting. On July 21, 2015, our nominee, Stephen
S. Burchett, was elected as a director with a mandate to maximize shareholder value. Subsequently, the CEO left the company. We
believe PBSK has failed to gain operational traction, and that PBSK should be sold.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
16 of 38
|
MB Bancorp, Inc.
(“MBCQ”)
- We filed our original Schedule 13D reporting our position on January 9, 2015. We urged management
and the board to repurchase shares and on March 30, 2016, MBCQ announced and subsequently completed its plan to repurchase an
initial 10% of its shares outstanding. We urged management and the board to complete the existing 5% share repurchase plan and
put MBCQ up for sale when permitted in January 2018. On February 20, 2018, we reached an agreement with MBCQ, and our representative,
Corissa J. Briglia, is appointed to the board of directors (effective March 27, 2018).
V.
Sound Financial,
Inc. (“SFBC”)
– We filed our original Schedule 13D reporting our position on November 21, 2011. We urged
management and the board to pursue a second step conversion. On August 22, 2012, Sound Financial Bancorp, Inc. (“SFBC”)
announced completion of its second step conversion and our shares of SNFL were converted into shares of SFBC. We support SFBC’s
consistent efforts to maximize shareholder value.
IF Bancorp, Inc.
(“IROQ”)
- We filed our original Schedule 13D reporting our position on March 5, 2012. We believe IROQ is positioned
to consistently repurchase its shares, and we have urged management and the board to do so. We believe IROQ must increase its
rate of share repurchases while the shares remain below book value.
Hamilton Bancorp,
Inc. (“HBK”)
- We filed our original Schedule 13D reporting our position on October 22, 2012. We believe HBK's
acquisition of FMTB and FRTR is in the best interest of shareholders.
Carroll Bancorp,
Inc. (“CROL”)
- We filed our original Schedule 13D reporting our position on March 17, 2014. We are evaluating
management and the board’s actions regarding maximizing shareholder value. CROL deregistered its shares of common stock
effective in 2017.
Central Federal
Bancshares, Inc. (“CFDB”)
- We filed our original Schedule 13D reporting our position on January 25, 2016. We
will urge management and the board to repurchase shares as soon as CFDB is permitted.
First Advantage
Bancorp (“FABK”)
- We filed our original Schedule 13D reporting our position on March 20, 2017. We believe
management and the board will act in good faith to maximize shareholder value over the long term. FABK deregistered its shares
of common stock effective in 2013.
CIB Marine Bancshares, Inc. (“CIBH”)
– We believe management and the board are acting in good faith to maximize shareholder value. CIBH deregistered its
shares of common stock effective in 2012.
West Town Bancorp, Inc. (“WTWB”)
–
We believe management and the board are acting in good faith to maximize shareholder value. WTWB deregistered its shares of common
stock effective in 2003.
Alcentra Capital Corp (“ABDC”)
-
We filed our original Schedule 13D reporting our position on December 28, 2017. We encourage ABDC to repurchase shares and
hope to work with its current board and management.
VI.
Wayne Savings Bancshares, Inc.
(“WAYN”)
- We filed our original Schedule 13D reporting our position on October 8, 2010. In 2014, we supported H. Stewart Fitz Gibbon III's
appointment as CEO and as a director on the board. We believed management and the board were acting in good faith to position
WAYN to maximize shareholder value. When the board announced Mr. Fitz Gibbon's unexplained resignation on December 20, 2016, we
nominated a director for election at WAYN's 2017 annual meeting. We lost by a narrow margin.
On December 26, 2017, we announced our
nominee and alternate nominee for WAYN's 2018 election of directors. We believe there have been multiple suitors interested in
acquiring WAYN, and that the board has a duty to evaluate strategic alternatives to maximize shareholder value.
Wheeler Real Estate Investment Trust,
Inc.
(“WHLR”) - We filed our original Schedule 13D reporting our position on July 3, 2017. On December 4,
2017, we announced our nominees and alternate nominee for WHLR’s 2018 election of directors. On January 17, 2018, we called
for Jon Wheeler’s removal from WHLR, and he was fired by the board on January 29, 2018.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
17 of 38
|
VII.
Ben Franklin Financial,
Inc. (“BFFI”)
- We filed our original Schedule 13D reporting our position on February 9, 2015. We urged management
and the board to repurchase shares as soon as BFFI was permitted. We now believe BFFI should be sold.
VIII.
NorthEast
Community Bancorp, Inc. (“NECB”)
- We filed our original Schedule 13D reporting our position on November 5, 2007.
A majority of NECB’s shares are held by a mutual holding company controlled by NECB’s board. We opposed the grant
of an equity incentive plan for the NECB board, and to this day, the board and management have not received such a plan. In
July of 2010, we delivered a written demand to NECB demanding to inspect its shareholder list, but NECB refused to supply us with
the list. We sued NECB in federal court in New York seeking an order compelling compliance. In August of 2010, NECB produced the
list of shareholders to us. In the fall of 2011, we sent a letter to NECB’s board of directors demanding that NECB
expand the board with disinterested directors to consider a second step conversion. In October of 2011, we filed a lawsuit in
New York state court against NECB, the mutual holding company, and their boards of directors, personally and derivatively, for
breach of fiduciary duty arising out of failure to fairly consider a second step conversion and alleging conflict of interest. During
the course of a protracted litigation, we deposed every named director including a former director. Although the New York
trial court judge agreed with us in partially granting our motion for summary judgment and finding that upon trial the defendants
would bear the burden of the entire fairness standard, the First Department reversed on other grounds; the New York Court of Appeals
declined to hear our appeal. NECB deregistered its shares of common stock effective in 2016.
Seneca-Cayuga Bancorp,
Inc. (“SCAY”)
- We filed our original Schedule 13D reporting our position on September 15, 2014. SCAY deregistered
its shares of common stock effective in 2009. We believed SCAY was positioned to provide meaningful returns to its shareholders
either through a second-step conversion or by effectuating a shareholder-friendly capital allocation program. We encouraged management
and the board to choose the path that would maximize shareholder value, but they chose neither path. On January 29, 2018, we served
a letter to the board demanding that SCAY undertake a second-step conversion.
Members of the Group
may seek to make additional purchases or sales of shares of Common Stock. Except as described in this filing, no member of the
Group has any plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through
(j), inclusive, of Item 4 of Schedule 13D. Members of the Group may, at any time and from time to time, review or reconsider their
positions and formulate plans or proposals with respect thereto.
Item 5. Interest in Securities of the
Issuer
The percentages used
in this filing are calculated based on the number of outstanding shares of Common Stock, 6,635,945, reported as of March 6, 2018,
in the Issuer’s Form 10-K filed with the Securities and Exchange Commission on March 15, 2018. The purchases and sales of
Common Stock reported in this item, if any, were made in open-market transactions.
|
(A)
|
Stilwell
Activist Fund
|
|
(a)
|
Aggregate
number of shares beneficially owned: 627,128
|
Percentage: 9.5%
|
(b)
|
1.
Sole power to vote or to direct vote: 0
|
2. Shared power to vote or to
direct vote: 627,128
3. Sole power to dispose or
to direct the disposition: 0
4. Shared power to dispose or
to direct disposition: 627,128
|
(c)
|
Stilwell
Activist Fund has not purchased or sold shares of Common Stock in the past 60 days.
|
(d) Because he is the managing
member and owner of Stilwell Value LLC, which is the general partner of Stilwell Activist Fund, Joseph Stilwell has the power
to direct the affairs of Stilwell Activist Fund, including the voting and disposition of shares of Common Stock held in the name
of Stilwell Activist Fund. Therefore, Joseph Stilwell is deemed to share voting and disposition power with Stilwell Activist Fund
with regard to those shares of Common Stock.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
18 of 38
|
|
(B)
|
Stilwell
Activist Investments
|
|
(a)
|
Aggregate
number of shares beneficially owned: 627,128
|
Percentage: 9.5%
|
(b)
|
1.
Sole power to vote or to direct vote: 0
|
2. Shared power to vote or to
direct vote: 627,128
3. Sole power to dispose or
to direct the disposition: 0
4. Shared power to dispose or
to direct disposition: 627,128
|
(c)
|
Stilwell
Activist Investments has not purchased or sold shares of Common Stock in the past 60
days.
|
(d) Because he is the managing
member and owner of Stilwell Value LLC, which is the general partner of Stilwell Activist Investments, Joseph Stilwell has the
power to direct the affairs of Stilwell Activist Investments, including the voting and disposition of shares of Common Stock held
in the name of Stilwell Activist Investments. Therefore, Joseph Stilwell is deemed to share voting and disposition power with
Stilwell Activist Investments with regard to those shares of Common Stock.
|
(a)
|
Aggregate
number of shares beneficially owned: 627,128
|
Percentage: 9.5%
|
(b)
|
1.
Sole power to vote or to direct vote: 0
|
2. Shared power to vote or to
direct vote: 627,128
3. Sole power to dispose or
to direct the disposition: 0
4. Shared power to dispose or
to direct disposition: 627,128
|
(c)
|
Stilwell
Associates has not purchased or sold shares of Common Stock in the past 60 days.
|
(d) Because he is the managing
member and owner of Stilwell Value LLC, which is the general partner of Stilwell Associates, Joseph Stilwell has the power to
direct the affairs of Stilwell Associates, including the voting and disposition of shares of Common Stock held in the name of
Stilwell Associates. Therefore, Joseph Stilwell is deemed to share voting and disposition power with Stilwell Associates with
regard to those shares of Common Stock.
|
(a)
|
Aggregate number
of shares beneficially owned: 627,128
|
Percentage: 9.5%
|
(b)
|
1.
Sole power to vote or to direct vote: 0
|
2. Shared power to vote or to
direct vote: 627,128
3. Sole power to dispose or
to direct the disposition: 0
4. Shared power to dispose or
to direct disposition: 627,128
|
(c)
|
Stilwell
Value LLC has made no purchases of shares of Common Stock.
|
(d) Because he is the managing
member and owner of Stilwell Value LLC, Joseph Stilwell has the power to direct the affairs of Stilwell Value LLC. Stilwell Value
LLC is the general partner of Stilwell Activist Fund, Stilwell Activist Investments and Stilwell Associates. Therefore, Stilwell
Value LLC may be deemed to share with Joseph Stilwell voting and disposition power with regard to the shares of Common Stock held
by Stilwell Activist Fund, Stilwell Activist Investments and Stilwell Associates.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
19 of 38
|
|
(a)
|
Aggregate
number of shares beneficially owned: 627,128
|
Percentage: 9.5%
|
(b)
|
1.
Sole power to vote or to direct vote: 0
|
2. Shared power to vote or to
direct vote: 627,128
3. Sole power to dispose or
to direct the disposition: 0
4. Shared power to dispose or
to direct disposition: 627,128
|
(c)
|
Joseph
Stilwell has made no purchases of shares of Common Stock.
|
Item 6. Contracts, Arrangements, Understandings
or Relationships With Respect to Securities of the Issuer
On March 12, 2018,
the Group entered into separate nominee agreements (each, a “Nominee Agreement” and, collectively, the “Nominee
Agreements”) with Mark D. Alcott, Stephen S. Burchett and Edward J. Fanning (collectively, the “Nominees”),
pursuant to which each Nominee has agreed, should the Group so elect, to stand for election to the Issuer’s board of directors
at the Issuer’s 2018 annual stockholder meeting and to serve as director if elected. Pursuant to the Nominee Agreements,
the Group has agreed to (i) reimburse all of each Nominee’s actual out-of-pocket expenses incurred in connection with the
nomination process and (ii) indemnify each Nominee for any damages and expenses incurred in connection with his nomination for
director of the Issuer. The foregoing summary of the Nominee Agreements is qualified in its entirety by reference to the full
text of the Nominee Agreements, copies of which are filed as Exhibits 16, 17 and 18 hereto and are incorporated by reference herein.
Other than the Nominee
Agreements and the Amended Joint Filing Agreement filed as Exhibit 9 to the Eighth Amendment, there are no contracts, arrangements,
understandings or relationships among the persons named in Item 2 hereof and between such persons and any person with respect
to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finders’ fees,
joint ventures, loan or option arrangements, puts or calls, guarantees of profits, divisions of profits or losses, or the giving
or withholding of proxies, except for sharing of profits. Stilwell Value LLC, in its capacity as general partner of Stilwell Activist
Fund, Stilwell Activist Investments and Stilwell Associates, and Joseph Stilwell, in his capacity as the managing member and owner
of Stilwell Value LLC, are entitled to an allocation of a portion of profits.
See Items 1 and 2
above regarding disclosure of the relationships between members of the Group, which disclosure is incorporated herein by reference.
Item 7. Material to be Filed as Exhibits
Exhibit
No.
|
|
Description
|
1
|
|
Joint Filing Agreement, dated February 25, 2013,
filed with the Original Schedule 13D
|
2
|
|
Nominee Agreement dated March 18, 2013, with
nominee Robert Bolton, filed with the First Amendment
|
3
|
|
Nominee Agreement dated March 18, 2013, with
alternate nominee, filed with the First Amendment
|
4
|
|
Stock Option Agreement dated March 18, 2013,
with nominee Robert Bolton, filed with the First Amendment
|
5
|
|
Amended Joint Filing Agreement, dated June 4,
2013, filed with the Third Amendment
|
6
|
|
Letter to Named Directors of HopFed Bancorp,
Inc., dated June 5, 2013, filed with the Fourth Amendment
|
7
|
|
Amended Joint Filing Agreement, dated July 2,
2014, filed with the Seventh Amendment
|
8
|
|
Letter to the Shareholders of HopFed Bancorp,
Inc., dated May 26, 2016, filed with the Eighth Amendment
|
9
|
|
Amended Joint Filing Agreement, dated May 26,
2016, filed with the Eighth Amendment
|
10
|
|
Letter to the Chief Executive Officer of HopFed
Bancorp, Inc., dated November 21, 2016, filed with the Ninth Amendment
|
11
|
|
Letter to Named Directors of HopFed Bancorp,
Inc., dated January 27, 2017, filed with the Tenth Amendment
|
12
|
|
Letter to the Chief Executive Officer of HopFed
Bancorp, Inc., dated February 6, 2017, filed with the Eleventh Amendment
|
13
|
|
Letter to the Stockholders of HopFed Bancorp,
Inc., dated May 1, 2017, filed with the Twelfth Amendment
|
14
|
|
Court transcript of the Rulings of the Delaware
Court of Chancery from Oral Argument on Plaintiffs’ Motion for Attorneys’ Fees and Expenses, dated February 7,
2018, filed with the Fourteenth Amendment
|
15
|
|
Letter to the Chairman of the Board of Directors
of HopFed Bancorp, Inc., dated February 23, 2018, filed with the Fifteenth Amendment
|
16
|
|
Nominee Agreement, dated March 12, 2018, with
Nominee Mark D. Alcott
|
17
|
|
Nominee Agreement, dated March 12, 2018, with
Alternate Nominee Stephen S. Burchett
|
18
|
|
Nominee Agreement, dated March 12, 2018, with
Alternate Nominee Edward J. Fanning
|
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
20 of 38
|
SIGNATURES
After reasonable inquiry
and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and
correct.
Date: March 19, 2018
|
STILWELL ACTIVIST FUND, L.P.
|
|
|
|
|
|
By:
|
STILWELL VALUE LLC
|
|
|
General Partner
|
|
|
|
|
|
|
/s/
Megan Parisi
|
|
|
By:
|
Megan Parisi
|
|
|
|
Member
|
|
|
|
STILWELL ACTIVIST INVESTMENTS, L.P.
|
|
|
|
|
|
By:
|
STILWELL VALUE LLC
|
|
|
General Partner
|
|
|
|
|
|
|
/s/
Megan Parisi
|
|
|
By:
|
Megan Parisi
|
|
|
|
Member
|
|
|
|
|
|
STILWELL ASSOCIATES, L.P.
|
|
|
|
|
|
By:
|
STILWELL VALUE LLC
|
|
|
General Partner
|
|
|
|
|
|
/s/
Megan Parisi
|
|
|
By:
|
Megan Parisi
|
|
|
|
Member
|
|
STILWELL VALUE LLC
|
|
|
|
/s/
Megan Parisi
|
|
By:
|
Megan Parisi
|
|
|
Member
|
|
|
|
JOSEPH STILWELL
|
|
|
|
/s/
Joseph Stilwell*
|
|
Joseph Stilwell
|
*/s/
Megan Parisi
|
|
Megan Parisi
|
|
Attorney-In-Fact
|
|
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
21 of 38
|
APPENDIX A
The participants in
this solicitation are anticipated to include Stilwell Activist Investments, L.P., a Delaware limited partnership (“Stilwell
Activist Investments”); Stilwell Activist Fund, L.P., a Delaware limited partnership (“Stilwell Activist Fund”);
Stilwell Associates, L.P., a Delaware limited partnership (“Stilwell Associates”); Stilwell Value LLC, a Delaware
limited liability company; and Joseph Stilwell (collectively, the “Beneficial Owners”), as well as Mark D. Alcott
(the “Nominee”) and Stephen S. Burchett and Edward J. Fanning (the “Alternate Nominees,” and collectively,
with the Beneficial Owners and the Nominee, the “Participants” and each a “Participant”).
Stilwell Activist
Investments intends to solicit proxies for the election of the Nominee, or any other person(s) nominated by Stilwell Activist
Investments, including the Alternate Nominees, as necessary, to the Board of Directors of HopFed Bancorp, Inc. (the “Corporation”)
at the 2018 Annual Meeting of Stockholders (the “Annual Meeting”) in accordance with applicable law and intends to
comply with applicable requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
With respect to each
Participant, other than as disclosed herein, such Participant is not and, within the past year, was not a party to any contract,
arrangement or understanding with any person with respect to any securities of the Corporation, including, but not limited to,
joint ventures, loan or option arrangements, puts or calls, guarantees against loss or guarantees of profit, division of losses
or profits, or the giving or withholding of proxies, except for sharing of profits. Stilwell Value LLC, in its capacity as general
partner of Stilwell Activist Investments, Stilwell Activist Fund, and Stilwell Associates, and Joseph Stilwell, in his capacity
as the managing member and sole owner of Stilwell Value LLC, are entitled to an allocation of a portion of profits. With respect
to each Participant, other than as disclosed below, neither such Participant nor any of such Participant’s associates has
any arrangement or understanding with any person with respect to (i) any future employment by the Corporation or its affiliates;
or (ii) any future transactions to which the Corporation or any of its affiliates will or may be a party.
Stilwell Activist
Investments, Stilwell Activist Fund, and Stilwell Associates (collectively, “Plaintiffs”) previously filed a lawsuit
on May 4, 2017, against the Corporation and its current directors and a former director individually in the Court of Chancery
in the State of Delaware (the “Lawsuit”) alleging, among other things, that the adoption on or about January 21, 2015,
of Article III, Section 13 of the Corporation’s Bylaws, as amended, was discriminatory and that the Corporation’s
board of directors violated its fiduciary duties by adopting the invalid Bylaw. After the Corporation amended Article III,
Section 13 of the Bylaws on October 4, 2017, thus mooting the Lawsuit, the parties agreed to dismiss the Lawsuit subject to the
Court’s consideration of Plaintiffs’ Fee and Expense Application. On February 7, 2018, the Court of Chancery
granted Plaintiffs’ Fee and Expense Application in full as set forth in the Rulings of the Court from Oral Argument on Plaintiffs’
Motion for Attorneys’ Fees and Expenses,
Stilwell Associates, L.P., et al. v. HopFed Bancorp, Inc., et al
. (Civil
Action No. 2017-0343-JTL).
Except as otherwise
set forth herein, (i) during the past 10 years, no Participant has been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors); (ii) no Participant directly or indirectly beneficially owns any securities of the Corporation;
(iii) no Participant owns any securities of the Corporation which are owned of record but not beneficially; (iv) no Participant
has purchased or sold any securities of the Corporation during the past two years; (v) no part of the purchase price or market
value of the securities of the Corporation owned by any Participant is represented by funds borrowed or otherwise obtained for
the purpose of acquiring or holding such securities; (vi) no Participant is, or within the past year was, a party to any contract,
arrangements or understandings with any person with respect to any securities of the Corporation, including, but not limited to,
joint ventures, loan or option arrangements, puts or calls, guarantees against loss or guarantees of profit, division of losses
or profits, or the giving or withholding of proxies; (vii) no associate of any Participant owns beneficially, directly or indirectly,
any securities of the Corporation; (viii) no Participant owns beneficially, directly or indirectly, any securities of any parent
or subsidiary of the Corporation; (ix) no Participant or any of his or its associates was a party to any transaction, or series
of similar transactions, since the beginning of the Corporation’s last fiscal year, or is a party to any currently proposed
transaction, or series of similar transactions, to which the Corporation or any of its subsidiaries was or is to be a party, in
which the amount involved exceeds $120,000; (x) no Participant or any of his or its associates has any arrangement or understanding
with any person with respect to any future employment by the Corporation or its affiliates, or with respect to any future transactions
to which the Corporation or any of its affiliates will or may be a party; (xi) no Participant has a substantial interest, direct
or indirect, by securities holdings or otherwise in any matter to be acted on at the Annual Meeting; (xii) no Participant holds
any positions or offices with the Corporation; (xiii) no Participant has a family relationship with any director, executive officer,
or person nominated or chosen by the Corporation to become a director or executive officer; and (xiv) no companies or organizations,
with which any of the Participants has been employed in the past five years, is a parent, subsidiary or other affiliate of the
Corporation. There are no material proceedings to which any Participant or any of his or its associates is a party adverse to
the Corporation or any of its subsidiaries or has a material interest adverse to the Corporation or any of its subsidiaries. Mr.
Fanning was Chairman and Vice President of Phoenix Building Solutions when it filed for bankruptcy in 2009. With respect to each
of the Nominee and Alternate Nominees, except as otherwise set forth herein, none of the events enumerated in Item 401(f)(1)-(8)
of Regulation S-K of the Exchange Act occurred during the past ten years.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
22 of 38
|
Security Ownership of Beneficial Owners
The table below shows the number of shares
of common stock, par value $0.01 per share, of the Corporation (“Common Stock”) held in accounts of the listed entities
or individuals.
Title of Class
|
|
Name of Owner
|
|
Direct Beneficial Ownership
|
|
|
Percent of Class (1)
|
|
Common Stock
|
|
Stilwell Activist Investments
|
|
|
530,611
|
|
|
|
8.0
|
%
|
Common Stock
|
|
Stilwell Activist Fund
|
|
|
76,517
|
|
|
|
1.2
|
%
|
Common Stock
|
|
Stilwell Associates
|
|
|
20,000
|
|
|
|
0.3
|
%
|
(1) The percentages are calculated based
on the number of outstanding shares of Common Stock, 6,635,945, reported as the number of outstanding shares as of March 6, 2018,
in the Corporation’s Form 10-K filed with the Securities and Exchange Commission on March 15, 2018 (the “Fourth Quarter
2017 Earnings Report”).
Stilwell Value LLC,
as the general partner of each of Stilwell Activist Investments, Stilwell Activist Fund, and Stilwell Associates, may be deemed
the beneficial owner of the 627,128 shares of Common Stock owned in the aggregate by Stilwell Activist Investments, Stilwell Activist
Fund, and Stilwell Associates. Mr. Stilwell, as the managing member and sole owner of Stilwell Value LLC, may be deemed the beneficial
owner of the 627,128 shares of Common Stock owned in the aggregate by Stilwell Activist Investments, Stilwell Activist Fund, and
Stilwell Associates.
Each of the Participants
disclaims beneficial ownership with respect to the shares of Common Stock reported owned in this notice except to the extent of
his or its pecuniary interest therein.
Security Ownership of Nominees
The Nominee and Alternate
Nominees do not directly or indirectly own any shares of Common Stock.
Description of Beneficial Ownership and Beneficial Owners
Joseph Stilwell is
the managing member and sole owner of Stilwell Value LLC, which is the general partner of Stilwell Activist Investments, Stilwell
Activist Fund, and Stilwell Associates. The business address of each Beneficial Owner is 111 Broadway, 12th Floor, New York, New
York 10006.
The principal employment
of Joseph Stilwell is investment management, and he serves as the managing member and sole owner of Stilwell Value LLC. Stilwell
Activist Investments, Stilwell Activist Fund, and Stilwell Associates are private investment partnerships engaged in the purchase
and sale of securities for their own accounts. Stilwell Value LLC is in the business of serving as the general partner of Stilwell
Activist Investments, Stilwell Activist Fund, Stilwell Associates, and related partnerships.
Because he is the
managing member and sole owner of Stilwell Value LLC, which is the general partner of Stilwell Activist Investments, Stilwell
Activist Fund, and Stilwell Associates, Joseph Stilwell has the power to direct the affairs of Stilwell Activist Investments,
Stilwell Activist Fund, and Stilwell Associates, including the voting and disposition of shares of Common Stock held in the name
of Stilwell Activist Investments, Stilwell Activist Fund, and Stilwell Associates. Therefore, Joseph Stilwell is deemed to share
voting and disposition power with Stilwell Activist Investments, Stilwell Activist Fund, and Stilwell Associates with regard to
those shares of Common Stock.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
23 of 38
|
The Beneficial Owners
may be deemed to beneficially own, in the aggregate, 627,128 shares of Common Stock, representing approximately 9.5% of the Corporation’s
outstanding shares of Common Stock (based upon the 6,635,945 shares of Common Stock reported as the number of outstanding shares
as of March 6, 2018, in the Fourth Quarter 2017 Earnings Report). The Beneficial Owners have an interest in the election of directors
at the Annual Meeting in their capacities as stockholders of the Corporation.
Two Year Summary Table
The following table
indicates the date of each purchase and sale of shares of Common Stock by each Participant within the past two years and the number
of shares of Common Stock in each purchase and sale.
Name
|
|
Date
|
|
Shares of Common Stock
Purchased/(Sold)
1
|
|
|
|
|
|
|
|
Stilwell Activist Investments
|
|
05/03/2016
|
|
|
2,608
|
|
|
|
|
|
|
|
|
Stilwell Activist Investments
|
|
05/04/2016
|
|
|
2,392
|
|
|
|
|
|
|
|
|
Stilwell Activist Investments
|
|
12/28/2017
|
|
|
20,000
|
|
|
|
|
|
|
|
|
Stilwell Associates
|
|
11/28/2017
|
|
|
(10,000
|
)
|
|
|
|
|
|
|
|
Stilwell Associates
|
|
12/28/2017
|
|
|
(20,000
|
)
|
Interest of Certain Persons in Matters to be Acted Upon
The Beneficial Owners
and the Nominee are parties to an agreement whereby, among other things, the Nominee has agreed to be nominated for election to
the Board of Directors of the Corporation at the Annual Meeting, and the Beneficial Owners have agreed to reimburse the Nominee
for his expenses incurred in connection with his nomination for election to the Board of Directors and to indemnify and hold him
harmless from and against all damages and claims that may arise in connection with being nominated for election to the Board of
Directors.
The Beneficial Owners
and the Alternate Nominees are parties to an agreement whereby, among other things, the Alternate Nominees have agreed to be nominated
for election to the Board of Directors of the Corporation at the Annual Meeting if the Nominee is unable to serve as a director,
and the Beneficial Owners have agreed to reimburse each of the Alternate Nominees for his expenses incurred in connection with
his nomination for election to the Board of Directors and to indemnify and hold him harmless from and against all damages and
claims which may arise in connection with being nominated for election to the Board of Directors.
1
Funds for share purchases
were provided from time to time in part by margin account loans from subsidiaries of Morgan Stanley extended in the ordinary course
of business. All purchases of shares of Common Stock using funds borrowed from Morgan Stanley, if any, were made in margin transactions
on their usual terms and conditions. All or part of the shares of Common Stock owned by the Beneficial Owners may from time to
time be pledged with one or more banking institutions or brokerage firms as collateral for loans made by such entities to such
entities. Such loans generally bear interest at a rate based on the broker's call rate from time to time in effect. Such indebtedness,
if any, may be refinanced with other banks or broker-dealers. There is currently no indebtedness outstanding secured by shares
of Common Stock held by the Beneficial Owners.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
24 of 38
|
The Nominee and Alternate
Nominees have an interest in the election of directors at the Annual Meeting by virtue of their service as the Nominee and Alternate
Nominees, as applicable, pursuant to the agreements described above. The Beneficial Owners have an interest in the election of
directors at the Annual Meeting directly or indirectly through the ownership of shares described under “Description of Beneficial
Ownership and Beneficial Owners” above.
Except as otherwise
set forth herein, neither the Nominee, the Alternate Nominees, nor any of their associates has any arrangement or understanding
with any person with respect to any future employment with the Corporation or its affiliates or with respect to any future transactions
to which the Corporation or any of its affiliates will or may be a party.
Information About the Nominee and Alternate
Nominees
The Beneficial Owners
believe that the Nominee and Alternate Nominees presently are, and if elected as a director of the Corporation, each would be,
an “independent director” within the meaning of (i) paragraph (a)(1) of Item 407 of Regulation S-K; (ii) NASDAQ Listing
Rule 5605; and (iii) Section 301 of the Sarbanes-Oxley Act of 2002.
The following information
was provided by the Nominee and Alternate Nominees, which each has certified as correct:
A.
Name, Age, Business Address and
Residence Address
Name
|
|
Age
|
|
Business
Address
|
|
Residence
Address
|
|
|
|
|
|
|
|
Mark D. Alcott
|
|
50
|
|
519 E. 10
th
Ave.
|
|
1340 College Street
|
|
|
|
|
Bowling Green, KY 42101
|
|
Bowling Green, KY 42101
|
|
|
|
|
|
|
|
Stephen S. Burchett
|
|
51
|
|
175 E. Main St., Suite 500
|
|
5024 King Richard Ct.
|
|
|
|
|
Lexington, KY 40507
|
|
Ashland, KY 41101
|
|
|
|
|
|
|
|
Edward J. Fanning
|
|
59
|
|
3600 Thayer Court
|
|
3205 Ivy Hills Boulevard
|
|
|
|
|
Aurora, IL 60504
|
|
Cincinnati, OH 45244
|
B.
Business Experience During the Past
Five Years
Mark D. Alcott
: Mr. Alcott
has served as Managing Partner of the law firm Harlin, Parker, Alcott & Chaudoin PSC for the past twenty years, where he represents,
among other clients, regional and national banks on commercial transactions and in litigation. Mr. Alcott also serves as
a director of H.P.R., Inc., a real estate holdings company, a position he has held since 1997. He previously served from 2005
to 2006 as Bowling Green City Commissioner tasked with improving internal controls. In addition, Mr. Alcott has served as a director
of various non-profit organizations. Mr. Alcott earned his J.D. from the University of Kentucky and his B.S. in Agri-Business
with Minors in Economics and Business Administration from Western Kentucky University. He is not employed by any parent, subsidiary
or other affiliate of the Corporation.
Stilwell Activist Investments
believes Mr. Alcott is qualified to serve on the Corporation’s Board of Directors given his extensive management and business
experience and expertise, together with his significant experience representing regional and national banks.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
25 of 38
|
Stephen S. Burchett
:
Mr. Burchett has been a member of the law firm Jackson Kelly PLLC since 2017 practicing with the Health Care Litigation Practice
Group based in Lexington, KY. Prior to that, Mr. Burchett was a partner with the law firm of Offutt Nord Burchett, PLLC from 2002
to 2017, where he was named one of The Best Lawyers in America™. Mr. Burchett has successfully represented a wide range
of clients in complex litigation throughout Central Appalachia. He is the only attorney practicing in the Tri-State who is board-certified
by the American Board of Professional Liability Attorneys. Mr. Burchett is originally from Morehead, KY and currently resides
in Ashland, KY. He attended the University of Virginia on the prestigious Jefferson Scholarship and received his law degree from
the University of Kentucky where he was president of the Student Bar Association. He has also served as a representative to the
Kentucky Bar Association Board of Governors. Since July 2015, Mr. Burchett has served on the Board of Directors of Poage Bankshares,
Inc. (NASDAQ:PBSK), the savings and loan holding company for Town Square Bank, where he currently serves on the Nominating Committee
and the Compensation Committee. Mr. Burchett is also on the Town Square Bank Board of Directors. He is not employed by any parent,
subsidiary or other affiliate of the Corporation.
Stilwell Activist Investments
believes Mr. Burchett is qualified to serve on the Corporation’s Board of Directors given his board experience at both Poage
Bankshares, Inc. and Town Square Bank, together with his extensive management and business experience, and experience advising
and providing legal guidance to boards of directors and officers.
Edward J. Fanning
: Mr.
Fanning is the President and Owner of Spectrum CXO, LLC, which provides management consulting services to businesses, a position
he has held since June 2017. Through Spectrum CXO, LLC, Mr. Fanning is currently acting CEO of The Labs Holdings, LLC, a technology
company focused on athletic training, performance, and injury prevention, a position he has held since October 2017. Previously,
from October 2013 to May 2017, Mr. Fanning was Managing Director of Union Springs, LLC, a healthcare startup company that was
recently acquired by Enzymotec. He was also previously the EVP & CFO of Duro Bag Manufacturing Company, a multimillion-dollar
packaging company, Senior Vice President and head of capital markets and loan syndications at Provident Financial Group, Inc.
(formerly NASDAQ: PFGI), the holding company for The Provident Bank, which was later sold, and Principal at Franklin Street Equity
Partners, a middle market private investment firm. Mr. Fanning earned his MBA from Northwestern University’s Kellogg
Graduate School of Management and his B.S. in Accountancy and Finance from Northern Illinois University. He is a Certified Public
Accountant (inactive) and a Certified Management Accountant (inactive).
Stilwell Activist Investments
believes Mr. Fanning is qualified to serve on the Corporation’s Board of Directors given his more than 30 years of experience
advising owners, boards, and CEOs of privately-held and publicly-traded companies with respect to corporate strategy, operational
turnarounds, profitability improvement, acquisitions, divestitures, and financing, together with his expertise in strategy, finance,
business processes, operations, corporate governance, and corporate development.
* * *
Neither the delivery
of the Notice of Intent to Nominate dated March 17, 2018, including all Exhibits thereto (collectively, the “Notice”),
nor the delivery by the Participants of any additional information to the Corporation from and after the date hereof shall be
deemed to constitute an admission by the Participants or any of their respective affiliates (if any) that such delivery is required
or that each and every item or any item of information is required or as to the legality or enforceability of any notice requirement
or any other matter, or a waiver by the Participants or any of their respective affiliates (if any) of their right to contest
or challenge, in any way, the validity or enforceability of any notice requirement or any other matter concerning the nomination
of individuals for election to the Board of Directors (including actions taken by the Board of Directors of the Corporation in
anticipation of, or following receipt of, the Notice). Furthermore, the Notice assumes that the Board of Directors will
nominate a total of three director nominees for election to the Board of Directors at the Annual Meeting, and if the Board of
Directors of the Corporation increases the number of directors to be nominated and elected at the Annual Meeting or a special
meeting called for a similar purpose, the Participants reserve the right to add additional director nominees in respect of each
such additional directorship. The Participants reserve the right to correct and/or supplement any statement or other information
set forth in the Notice.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
26 of 38
|
Exhibit 16
NOMINEE AGREEMENT
This Nominee Agreement
is made this 12
th
day of March 2018, by and among Stilwell Associates, L.P., Stilwell Activist Investments, L.P., and
Stilwell Activist Fund, L.P., (collectively, the “
Stilwell Funds
”), and their General Partner, Stilwell Value
LLC (“
Stilwell Value
” and together with the Stilwell Funds, “
The Stilwell Group
”), having
their principal places of business at 111 Broadway, 12
th
Floor, New York, NY 10006, and Mark D. Alcott, an individual
with offices at 519 East 10
th
Avenue, Bowling Green, KY 42101 (“
Nominee
”).
WHEREAS, The Stilwell
Group and its affiliates are the beneficial owners of shares of common stock (“
Common Stock
”) of HopFed Bancorp,
Inc. (“
HFBC
” or the “
Company
”), may solicit proxies to elect one or more nominees to HFBC’s
Board of Directors (the “
Board
”) at the 2018 annual meeting of stockholders of HFBC (the “
Meeting
”),
and wish to nominate Nominee for election to the Board at the Meeting;
WHEREAS, Nominee desires
and agrees to be nominated for and to serve on the Board if elected at the Meeting for a term to expire at the 2021 annual meeting
of stockholders of HFBC and until his respective successor is duly elected and qualified;
NOW, THEREFORE, in
consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
the parties agree as follows:
1. Nominee
hereby agrees to have his name placed in nomination by The Stilwell Group as its nominee for election to the Board, and for that
purpose, understands and agrees that The Stilwell Group will solicit proxies from stockholders to cause Nominee to be elected.
Simultaneously with the execution of this Agreement, Nominee shall deliver his written consent to The Stilwell Group to be named
in The Stilwell Group’s proxy statement and to serve as a director of HFBC if elected, a copy of which is attached hereto
as
Exhibit A
. Nominee understands that The Stilwell Group retains the right to determine whether Nominee will be its alternate
or actual nominee and will so advise Nominee of its determination prior to the solicitation of proxies. Nominee understands that
an alternate nominee may become the actual nominee if the actual nominee does not stand for election.
2. Nominee
hereby represents and warrants to The Stilwell Group that he has executed and delivered to The Stilwell Group a Confidential Director
Questionnaire and hereby certifies that the contents thereof are true and correct and that he will promptly notify The Stilwell
Group of any change in such contents.
3. Nominee
hereby represents and warrants to The Stilwell Group that he will not acquire, directly or indirectly, any HFBC Common Stock,
whether beneficially (as defined in Rule 13d-3 under the Securities Exchange Act of 1934) or of record, from the date hereof until
the conclusion of the Meeting and that he has notified all business partners, associates, family members and other entities or
individuals with which he might share such beneficial ownership of HFBC Common Stock that no HFBC Common Stock may be purchased
during such time.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
27 of 38
|
4. The
Stilwell Group agrees to reimburse all of Nominee’s actual out-of-pocket expenses incurred in connection with the nomination
process until the conclusion of the Meeting, including telephone, postage, and travel.
5.
Nominee and The Stilwell Group agree that in the event Nominee is elected as a director of HFBC, nothing in this Agreement shall
be construed as affecting Nominee’s ability to act independently with respect to his responsibilities and decisions as a
director which shall be governed by applicable law and subject to Nominee’s fiduciary duty to the stockholders of the Company.
6. The
Stilwell Group hereby indemnifies and holds Nominee harmless for all damages and expenses incurred in connection with agreeing
to have his name placed in nomination and to have proxies solicited in order to elect him to the Board (the “
Solicitation
”);
provided, however, that Nominee will not be entitled to indemnification for claims arising from his gross negligence, willful
misconduct, intentional and material violations of law, criminal actions or material breach of the terms of this Agreement; provided
further, that upon becoming a director of HFBC, this indemnification shall not apply to any claims made against him in his capacity
as a director of HFBC. This indemnification will include any and all losses, liabilities, damages, demands, claims, suits, actions,
judgments, or causes of action, assessments, costs and expenses, including, without limitation, interest, penalties, reasonable
attorneys’ fees, and any and all reasonable costs and expenses incurred in investigating, preparing or defending against
any litigation, commenced or threatened, any civil, criminal, administrative or arbitration action, or any claim whatsoever, and
any and all amounts paid in settlement of any claim or litigation asserted against, resulting, imposed upon, or incurred or suffered
by Nominee, directly or indirectly, as a result of or arising from the Solicitation and any related transactions (each, a “
Loss
”).
In the event of a claim against Nominee or the occurrence of a Loss, Nominee shall give The Stilwell Group notice thereof no later
than ten (10) days after Nominee has knowledge of such claim or Loss (provided that failure to promptly notify The Stilwell Group
shall not relieve it from any liability which it may have on account of this Section 6, except to the extent it shall have been
materially prejudiced by such failure). The Stilwell Group retains the sole right to select and retain counsel for Nominee and
shall reimburse Nominee for all Losses suffered as provided herein.
7. The
obligations of The Stilwell Group under this Agreement are contingent upon The Stilwell Group’s determination, in its sole
discretion, after final completion of a due diligence review of Nominee’s background, that Nominee is a suitable candidate
for the Board.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
28 of 38
|
8. Nominee
understands that this Agreement may be publicly disclosed by The Stilwell Group.
|
/s/ Megan Parisi
|
|
Megan Parisi on behalf of The Stilwell Group
|
|
|
|
/s/ Mark D. Alcott
|
|
Mark D. Alcott, Nominee
|
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
29 of 38
|
EXHIBIT A
CONSENT OF PROPOSED NOMINEE
I, Mark D. Alcott, hereby
consent to be named and described as a nominee for election as a director of HopFed Bancorp, Inc. (“HFBC”), in the
proxy statement and other related written materials and public filings of Stilwell Associates, L.P., Stilwell Activist Investments,
L.P., and Stilwell Activist Fund, L.P., and their respective affiliates (collectively, “The Stilwell Group”) to be
used in connection with The Stilwell Group’s solicitation of proxies from the stockholders of HFBC, for use in voting at
the 2018 annual meeting of stockholders of HFBC (the “Annual Meeting”), and I hereby consent and agree to serve as
a director of HFBC if elected at the Annual Meeting.
|
/s/ Mark D. Alcott
|
|
Mark D. Alcott
|
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
30 of 38
|
Exhibit 17
NOMINEE AGREEMENT
This Nominee Agreement
is made this 12
th
day of March 2018, by and among Stilwell Associates, L.P., Stilwell Activist Investments, L.P., and
Stilwell Activist Fund, L.P., (collectively, the “
Stilwell Funds
”), and their General Partner, Stilwell Value
LLC (“
Stilwell Value
” and together with the Stilwell Funds, “
The Stilwell Group
”), having
their principal places of business at 111 Broadway, 12
th
Floor, New York, NY 10006, and Stephen S. Burchett, an individual
with offices at 175 E. Main Street, Suite 500, Lexington, KY 40507 (“
Nominee
”).
WHEREAS, The Stilwell
Group and its affiliates are the beneficial owners of shares of common stock (“
Common Stock
”) of HopFed Bancorp,
Inc. (“
HFBC
” or the “
Company
”), may solicit proxies to elect one or more nominees to HFBC’s
Board of Directors (the “
Board
”) at the 2018 annual meeting of stockholders of HFBC (the “
Meeting
”),
and wish to nominate Nominee for election to the Board at the Meeting;
WHEREAS, Nominee desires
and agrees to be nominated for and to serve on the Board if elected at the Meeting for a term to expire at the 2021 annual meeting
of stockholders of HFBC and until his respective successor is duly elected and qualified;
NOW, THEREFORE, in
consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
the parties agree as follows:
1. Nominee
hereby agrees to have his name placed in nomination by The Stilwell Group as its nominee for election to the Board, and for that
purpose, understands and agrees that The Stilwell Group will solicit proxies from stockholders to cause Nominee to be elected.
Simultaneously with the execution of this Agreement, Nominee shall deliver his written consent to The Stilwell Group to be named
in The Stilwell Group’s proxy statement and to serve as a director of HFBC if elected, a copy of which is attached hereto
as
Exhibit A
. Nominee understands that The Stilwell Group retains the right to determine whether Nominee will be its alternate
or actual nominee and will so advise Nominee of its determination prior to the solicitation of proxies. Nominee understands that
an alternate nominee may become the actual nominee if the actual nominee does not stand for election.
2. Nominee
hereby represents and warrants to The Stilwell Group that he has executed and delivered to The Stilwell Group a Confidential Director
Questionnaire and hereby certifies that the contents thereof are true and correct and that he will promptly notify The Stilwell
Group of any change in such contents.
3. Nominee
hereby represents and warrants to The Stilwell Group that he will not acquire, directly or indirectly, any HFBC Common Stock,
whether beneficially (as defined in Rule 13d-3 under the Securities Exchange Act of 1934) or of record, from the date hereof until
the conclusion of the Meeting and that he has notified all business partners, associates, family members and other entities or
individuals with which he might share such beneficial ownership of HFBC Common Stock that no HFBC Common Stock may be purchased
during such time.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
31 of 38
|
4. The
Stilwell Group agrees to reimburse all of Nominee’s actual out-of-pocket expenses incurred in connection with the nomination
process until the conclusion of the Meeting, including telephone, postage, and travel.
5. Nominee
and The Stilwell Group agree that in the event Nominee is elected as a director of HFBC, nothing in this Agreement shall be construed
as affecting Nominee’s ability to act independently with respect to his responsibilities and decisions as a director which
shall be governed by applicable law and subject to Nominee’s fiduciary duty to the stockholders of the Company.
6. The
Stilwell Group hereby indemnifies and holds Nominee harmless for all damages and expenses incurred in connection with agreeing
to have his name placed in nomination and to have proxies solicited in order to elect him to the Board (the “
Solicitation
”);
provided, however, that Nominee will not be entitled to indemnification for claims arising from his gross negligence, willful
misconduct, intentional and material violations of law, criminal actions or material breach of the terms of this Agreement; provided
further, that upon becoming a director of HFBC, this indemnification shall not apply to any claims made against him in his capacity
as a director of HFBC. This indemnification will include any and all losses, liabilities, damages, demands, claims, suits, actions,
judgments, or causes of action, assessments, costs and expenses, including, without limitation, interest, penalties, reasonable
attorneys’ fees, and any and all reasonable costs and expenses incurred in investigating, preparing or defending against
any litigation, commenced or threatened, any civil, criminal, administrative or arbitration action, or any claim whatsoever, and
any and all amounts paid in settlement of any claim or litigation asserted against, resulting, imposed upon, or incurred or suffered
by Nominee, directly or indirectly, as a result of or arising from the Solicitation and any related transactions (each, a “
Loss
”).
In the event of a claim against Nominee or the occurrence of a Loss, Nominee shall give The Stilwell Group notice thereof no later
than ten (10) days after Nominee has knowledge of such claim or Loss (provided that failure to promptly notify The Stilwell Group
shall not relieve it from any liability which it may have on account of this Section 6, except to the extent it shall have been
materially prejudiced by such failure). The Stilwell Group retains the sole right to select and retain counsel for Nominee and
shall reimburse Nominee for all Losses suffered as provided herein.
7. The
obligations of The Stilwell Group under this Agreement are contingent upon The Stilwell Group’s determination, in its sole
discretion, after final completion of a due diligence review of Nominee’s background, that Nominee is a suitable candidate
for the Board.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
32 of 38
|
8. Nominee
understands that this Agreement may be publicly disclosed by The Stilwell Group.
|
/s/ Megan Parisi
|
|
Megan Parisi on behalf of The Stilwell Group
|
|
|
|
/s/ Stephen S. Burchett
|
|
Stephen S. Burchett, Nominee
|
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
33 of 38
|
EXHIBIT A
CONSENT OF PROPOSED NOMINEE
I, Stephen S. Burchett,
hereby consent to be named and described as a nominee for election as a director of HopFed Bancorp, Inc. (“HFBC”),
in the proxy statement and other related written materials and public filings of Stilwell Associates, L.P., Stilwell Activist
Investments, L.P., and Stilwell Activist Fund, L.P., and their respective affiliates (collectively, “The Stilwell Group”)
to be used in connection with The Stilwell Group’s solicitation of proxies from the stockholders of HFBC, for use in voting
at the 2018 annual meeting of stockholders of HFBC (the “Annual Meeting”), and I hereby consent and agree to serve
as a director of HFBC if elected at the Annual Meeting.
|
/s/ Stephen S. Burchett
|
|
Stephen S. Burchett
|
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
34 of 38
|
Exhibit
18
NOMINEE AGREEMENT
This Nominee Agreement
is made this 12
th
day of March 2018, by and among Stilwell Associates, L.P., Stilwell Activist Investments, L.P., and
Stilwell Activist Fund, L.P., (collectively, the “
Stilwell Funds
”), and their General Partner, Stilwell Value
LLC (“
Stilwell Value
” and together with the Stilwell Funds, “
The Stilwell Group
”), having
their principal places of business at 111 Broadway, 12
th
Floor, New York, NY 10006, and Edward J. Fanning, an individual
with offices at 3600 Thayer Court, Aurora, IL 60504(“
Nominee
”).
WHEREAS, The Stilwell
Group and its affiliates are the beneficial owners of shares of common stock (“
Common Stock
”) of HopFed Bancorp,
Inc. (“
HFBC
” or the “
Company
”), may solicit proxies to elect one or more nominees to HFBC’s
Board of Directors (the “
Board
”) at the 2018 annual meeting of stockholders of HFBC (the “
Meeting
”),
and wish to nominate Nominee for election to the Board at the Meeting;
WHEREAS, Nominee desires
and agrees to be nominated for and to serve on the Board if elected at the Meeting for a term to expire at the 2021 annual meeting
of stockholders of HFBC and until his respective successor is duly elected and qualified;
NOW, THEREFORE, in
consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
the parties agree as follows:
1. Nominee
hereby agrees to have his name placed in nomination by The Stilwell Group as its nominee for election to the Board, and for that
purpose, understands and agrees that The Stilwell Group will solicit proxies from stockholders to cause Nominee to be elected.
Simultaneously with the execution of this Agreement, Nominee shall deliver his written consent to The Stilwell Group to be named
in The Stilwell Group’s proxy statement and to serve as a director of HFBC if elected, a copy of which is attached hereto
as
Exhibit A
. Nominee understands that The Stilwell Group retains the right to determine whether Nominee will be its alternate
or actual nominee and will so advise Nominee of its determination prior to the solicitation of proxies. Nominee understands that
an alternate nominee may become the actual nominee if the actual nominee does not stand for election.
2. Nominee
hereby represents and warrants to The Stilwell Group that he has executed and delivered to The Stilwell Group a Confidential Director
Questionnaire and hereby certifies that the contents thereof are true and correct and that he will promptly notify The Stilwell
Group of any change in such contents.
3. Nominee
hereby represents and warrants to The Stilwell Group that he will not acquire, directly or indirectly, any HFBC Common Stock,
whether beneficially (as defined in Rule 13d-3 under the Securities Exchange Act of 1934) or of record, from the date hereof until
the conclusion of the Meeting and that he has notified all business partners, associates, family members and other entities or
individuals with which he might share such beneficial ownership of HFBC Common Stock that no HFBC Common Stock may be purchased
during such time.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
35 of 38
|
4. The
Stilwell Group agrees to reimburse all of Nominee’s actual out-of-pocket expenses incurred in connection with the nomination
process until the conclusion of the Meeting, including telephone, postage, and travel.
5. Nominee
and The Stilwell Group agree that in the event Nominee is elected as a director of HFBC, nothing in this Agreement shall be construed
as affecting Nominee’s ability to act independently with respect to his responsibilities and decisions as a director which
shall be governed by applicable law and subject to Nominee’s fiduciary duty to the stockholders of the Company.
6. The
Stilwell Group hereby indemnifies and holds Nominee harmless for all damages and expenses incurred in connection with agreeing
to have his name placed in nomination and to have proxies solicited in order to elect him to the Board (the “
Solicitation
”);
provided, however, that Nominee will not be entitled to indemnification for claims arising from his gross negligence, willful
misconduct, intentional and material violations of law, criminal actions or material breach of the terms of this Agreement; provided
further, that upon becoming a director of HFBC, this indemnification shall not apply to any claims made against him in his capacity
as a director of HFBC. This indemnification will include any and all losses, liabilities, damages, demands, claims, suits, actions,
judgments, or causes of action, assessments, costs and expenses, including, without limitation, interest, penalties, reasonable
attorneys’ fees, and any and all reasonable costs and expenses incurred in investigating, preparing or defending against
any litigation, commenced or threatened, any civil, criminal, administrative or arbitration action, or any claim whatsoever, and
any and all amounts paid in settlement of any claim or litigation asserted against, resulting, imposed upon, or incurred or suffered
by Nominee, directly or indirectly, as a result of or arising from the Solicitation and any related transactions (each, a “
Loss
”).
In the event of a claim against Nominee or the occurrence of a Loss, Nominee shall give The Stilwell Group notice thereof no later
than ten (10) days after Nominee has knowledge of such claim or Loss (provided that failure to promptly notify The Stilwell Group
shall not relieve it from any liability which it may have on account of this Section 6, except to the extent it shall have been
materially prejudiced by such failure). The Stilwell Group retains the sole right to select and retain counsel for Nominee and
shall reimburse Nominee for all Losses suffered as provided herein.
7. The
obligations of The Stilwell Group under this Agreement are contingent upon The Stilwell Group’s determination, in its sole
discretion, after final completion of a due diligence review of Nominee’s background, that Nominee is a suitable candidate
for the Board.
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
36 of 38
|
8. Nominee
understands that this Agreement may be publicly disclosed by The Stilwell Group.
|
/s/ Megan Parisi
|
|
Megan Parisi on behalf of The Stilwell Group
|
|
|
|
/s/ Edward J. Fanning
|
|
Edward J. Fanning, Nominee
|
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
37 of 38
|
EXHIBIT A
CONSENT OF PROPOSED NOMINEE
I, Edward J. Fanning, hereby consent to be
named and described as a nominee for election as a director of HopFed Bancorp, Inc. (“HFBC”), in the proxy statement
and other related written materials and public filings of Stilwell Associates, L.P., Stilwell Activist Investments, L.P., and
Stilwell Activist Fund, L.P., and their respective affiliates (collectively, “The Stilwell Group”) to be used in connection
with The Stilwell Group’s solicitation of proxies from the stockholders of HFBC, for use in voting at the 2018 annual meeting
of stockholders of HFBC (the “Annual Meeting”), and I hereby consent and agree to serve as a director of HFBC if elected
at the Annual Meeting.
|
/s/ Edward J. Fanning
|
|
Edward J. Fanning
|
CUSIP
No. 439734104
|
SCHEDULE
13D
|
Page
38 of 38
|
SCHEDULE A
On March 16, 2015,
Stilwell Value LLC (“Value”) and Joseph Stilwell consented to the entry of an administrative SEC order (the “Order”)
that, among other things, alleged civil violations of the Investment Advisers Act of 1940 and certain rules promulgated thereunder
for failing to adequately disclose conflicts of interest presented by certain inter-fund loans. No investor suffered monetary
loss from the alleged conduct. The Order: (1) required Value and Joseph Stilwell to cease and desist from committing future violations;
(2) suspended Joseph Stilwell from association with any broker, dealer, investment adviser, or certain other regulated organizations
for a period of twelve months from entry and imposed upon him a $100,000 civil penalty; (3) censured Value and imposed upon it
the obligations to repay $239,157 in fees and to pay a $250,000 civil penalty; and (4) required Value to retain an independent
monitor for a period of three years from entry to review and assess the adequacy of certain of its policies, procedures, controls,
and disclosures. All penalty and repayment obligations set forth in the Order have been fully discharged.